SIGA Technologies - TPOXX trials launched in treating monkeypox
SIGA Technologies has shared an update on the progress of three clinical trials assessing TPOXX for treating monkeypox. Recently, three randomized,...
767 Views
SIGA Technologies - Second contract win from the US DoD in 2022
SIGA Technologies has announced a second procurement contract worth up to $10.7m from the US Department of Defense (DoD) for the procurement of...
754 Views
SIGA Technologies - Monkeypox concern drives international TPOXX win
SIGA Technologies (SIGA) has announced receipt of $16m of international procurement orders in the European Union (EU) and the Asia-Pacific region...
729 Views
SIGA Technologies - Monkeypox likely here to stay
With approximately 64k global cases, monkeypox has become a growing concern and is less transient than initially acknowledged. We expect SIGA...
755 Views
SIGA Technologies - BARDA exercises first option for IV TPOXX
Following strong Q222 results, SIGA Technologies has announced that the Biomedical Advanced Research and Development Authority (BARDA) has...
452 Views